会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E
    • 禽类戊型肝炎病毒,疫苗和防止禽流感 - 脾肿大综合征和哺乳动物性肝炎的方法
    • US07582303B2
    • 2009-09-01
    • US11184574
    • 2005-07-19
    • Xiang-Jin MengGholamreza HaqshenasFang-Fang Huang
    • Xiang-Jin MengGholamreza HaqshenasFang-Fang Huang
    • A61K39/29C12Q1/70C12Q1/68
    • C07K14/005A61K2039/5254A61K2039/54C12N7/00C12N2770/28022C12N2770/28034C12Q1/707G01N33/576
    • The present invention relates to a novel isolated avian hepatitis E virus having a nucleotide sequence set forth in SEQ ID NO:1 or its complementary strand. The invention further concerns immunogenic compositions comprising this new virus or recombinant products such as the nucleic acid and vaccines that protect an avian or mammalian species from viral infection or hepatitis-splenomegaly syndrome caused by the hepatitis E virus. Also included in the scope of the invention is a method for propagating, inactivating or attenuating a hepatitis E virus comprising inoculating an embryonated chicken egg with a live, pathogenic hepatitis E virus and recovering the virus or serially passing the pathogenic virus through additional embryonated chicken eggs until the virus is rendered inactivated or attenuated. Further, this invention concerns diagnostic reagents for detecting an avian hepatitis E viral infection or diagnosing hepatitis-splenomegaly syndrome in an avian or mammalian species comprising an antibody raised or produced against the immunogenic compositions and antigens such as ORF2 proteins expressed in a baculovirus vector, E. coli, etc. The invention additionally encompasses methods for detecting avian HEV nucleic acid sequences using nucleic acid hybridization probes or oligonucleotide primers for polymerase chain reaction (PCR).
    • 本发明涉及具有SEQ ID NO:1所示核苷酸序列或其互补链的新颖的分离型禽类戊型肝炎病毒。 本发明还涉及包含这种新病毒或重组产物(例如核酸和疫苗)的免疫原性组合物,其保护禽类或哺乳动物物种免受由戊型肝炎病毒引起的病毒感染或肝炎 - 脾肿大综合症。 本发明的范围还包括传播,灭活或减毒戊型肝炎病毒的方法,包括用活的致病性戊型肝炎病毒接种含胚鸡蛋,并回收该病毒或通过另外的含胚鸡蛋串联通过病原性病毒 直到病毒灭活或减毒。 此外,本发明涉及用于检测禽流感病毒感染或诊断禽流感或哺乳动物物种中的肝炎 - 脾肿大综合征的诊断试剂,其包含针对免疫原性组合物产生或产生的抗体,例如杆状病毒载体中表达的ORF2蛋白 大肠杆菌等。本发明另外包括使用核酸杂交探针或用于聚合酶链反应(PCR)的寡核苷酸引物检测禽类HEV核酸序列的方法。
    • 2. 发明申请
    • Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E
    • 禽类戊型肝炎病毒,疫苗和防止禽流感 - 脾肿大综合征和哺乳动物性肝炎的方法
    • US20050255461A1
    • 2005-11-17
    • US11184574
    • 2005-07-19
    • Xiang-Jin MengGholamreza HaqshenasFang-Fang Huang
    • Xiang-Jin MengGholamreza HaqshenasFang-Fang Huang
    • C07K14/08C12N7/00C12N15/38C12Q1/70G01N33/576C07H21/04C07K14/02
    • C07K14/005A61K2039/5254A61K2039/54C12N7/00C12N2770/28022C12N2770/28034C12Q1/707G01N33/576
    • The present invention relates to a novel isolated avian hepatitis E virus having a nucleotide sequence set forth in SEQ ID NO:1 or its complementary strand. The invention further concerns immunogenic compositions comprising this new virus or recombinant products such as the nucleic acid and vaccines that protect an avian or mammalian species from viral infection or hepatitis-splenomegaly syndrome caused by the hepatitis E virus. Also included in the scope of the invention is a method for propagating, inactivating or attenuating a hepatitis E virus comprising inoculating an embryonated chicken egg with a live, pathogenic hepatitis E virus and recovering the virus or serially passing the pathogenic virus through additional embryonated chicken eggs until the virus is rendered inactivated or attenuated. Further, this invention concerns diagnostic reagents for detecting an avian hepatitis E viral infection or diagnosing hepatitis-splenomegaly syndrome in an avian or mammalian species comprising an antibody raised or produced against the immunogenic compositions and antigens such as ORF2 proteins expressed in a baculovirus vector, E. coli, etc. The invention additionally encompasses methods for detecting avian HEV nucleic acid sequences using nucleic acid hybridization probes or oligonucleotide primers for polymerase chain reaction (PCR).
    • 本发明涉及具有SEQ ID NO:1所示核苷酸序列或其互补链的新颖的分离型禽类戊型肝炎病毒。 本发明还涉及包含这种新病毒或重组产物(例如核酸和疫苗)的免疫原性组合物,其保护禽类或哺乳动物物种免受由戊型肝炎病毒引起的病毒感染或肝炎 - 脾肿大综合症。 本发明的范围还包括传播,灭活或减毒戊型肝炎病毒的方法,包括用活的致病性戊型肝炎病毒接种含胚鸡蛋,并回收该病毒或通过另外的含胚鸡蛋串联通过病原性病毒 直到病毒灭活或减毒。 此外,本发明涉及用于检测禽流感病毒感染或诊断禽流感或哺乳动物物种中的肝炎 - 脾肿大综合征的诊断试剂,其包含针对免疫原性组合物产生或产生的抗体,例如杆状病毒载体中表达的ORF2蛋白 大肠杆菌等。本发明另外包括使用核酸杂交探针或用于聚合酶链反应(PCR)的寡核苷酸引物检测禽类HEV核酸序列的方法。
    • 4. 发明授权
    • Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E
    • 禽类戊型肝炎病毒,疫苗和防止禽流感 - 脾肿大综合征和哺乳动物性肝炎的方法
    • US07842298B2
    • 2010-11-30
    • US12507576
    • 2009-07-22
    • Xiang-Jin MengGholamreza HaqshenasFang-Fang Huang
    • Xiang-Jin MengGholamreza HaqshenasFang-Fang Huang
    • A16K39/12A61K39/29C12Q1/70C12Q1/68
    • C07K14/005A61K2039/5254A61K2039/54C12N7/00C12N2770/28022C12N2770/28034C12Q1/707G01N33/576
    • The present invention relates to a novel isolated avian hepatitis E virus having a nucleotide sequence set forth in SEQ ID NO:1 or its complementary strand. The invention further concerns immunogenic compositions comprising this new virus or recombinant products such as the nucleic acid and vaccines that protect an avian or mammalian species from viral infection or hepatitis-splenomegaly syndrome caused by the hepatitis E virus. Also included in the scope of the invention is a method for propagating, inactivating or attenuating a hepatitis E virus comprising inoculating an embryonated chicken egg with a live, pathogenic hepatitis E virus and recovering the virus or serially passing the pathogenic virus through additional embryonated chicken eggs until the virus is rendered inactivated or attenuated. Further, this invention concerns diagnostic reagents for detecting an avian hepatitis E viral infection or diagnosing hepatitis-splenomegaly syndrome in an avian or mammalian species comprising an antibody raised or produced against the immunogenic compositions and antigens such as ORF2 proteins expressed in a baculovirus vector, E. coli, etc. The invention additionally encompasses methods for detecting avian HEV nucleic acid sequences using nucleic acid hybridization probes or oligonucleotide primers for polymerase chain reaction (PCR).
    • 本发明涉及具有SEQ ID NO:1所示核苷酸序列或其互补链的新颖的分离型禽类戊型肝炎病毒。 本发明还涉及包含这种新病毒或重组产物(例如核酸和疫苗)的免疫原性组合物,其保护禽类或哺乳动物物种免受由戊型肝炎病毒引起的病毒感染或肝炎 - 脾肿大综合症。 本发明的范围还包括传播,灭活或减毒戊型肝炎病毒的方法,包括用活的致病性戊型肝炎病毒接种含胚鸡蛋,并回收该病毒或通过另外的含胚鸡蛋串联通过病原性病毒 直到病毒灭活或减毒。 此外,本发明涉及用于检测禽流感病毒感染或诊断禽流感或哺乳动物物种中的肝炎 - 脾肿大综合征的诊断试剂,其包含针对免疫原性组合物产生或产生的抗体,例如杆状病毒载体中表达的ORF2蛋白 大肠杆菌等。本发明另外包括使用核酸杂交探针或用于聚合酶链反应(PCR)的寡核苷酸引物检测禽类HEV核酸序列的方法。
    • 5. 发明申请
    • AVIAN HEPATITIS E VIRUS, VACCINES AND METHODS OF PROTECTING AGAINST AVIAN HEPATITIS-SPLENOMEGALY SYNDROME AND MAMMALIAN HEPATITIS E
    • AVIAN HEPATITIS E病毒,疫苗和防治AVIAN HEPATITIS-SPLENOMEGALY SYNDROME和MAMMALIAN HEPATITIS E的方法
    • US20100034845A1
    • 2010-02-11
    • US12507576
    • 2009-07-22
    • Xiang-Jin MengGholamreza HaqshenasFang-Fang Huang
    • Xiang-Jin MengGholamreza HaqshenasFang-Fang Huang
    • A61K39/29C07H21/04C07K14/02A61K31/7088C12Q1/70
    • C07K14/005A61K2039/5254A61K2039/54C12N7/00C12N2770/28022C12N2770/28034C12Q1/707G01N33/576
    • The present invention relates to a novel isolated avian hepatitis E virus having a nucleotide sequence set forth in SEQ ID NO:1 or its complementary strand. The invention further concerns immunogenic compositions comprising this new virus or recombinant products such as the nucleic acid and vaccines that protect an avian or mammalian species from viral infection or hepatitis-splenomegaly syndrome caused by the hepatitis E virus. Also included in the scope of the invention is a method for propagating, inactivating or attenuating a hepatitis E virus comprising inoculating an embryonated chicken egg with a live, pathogenic hepatitis E virus and recovering the virus or serially passing the pathogenic virus through additional embryonated chicken eggs until the virus is rendered inactivated or attenuated. Further, this invention concerns diagnostic reagents for detecting an avian hepatitis E viral infection or diagnosing hepatitis-splenomegaly syndrome in an avian or mammalian species comprising an antibody raised or produced against the immunogenic compositions and antigens such as ORF2 proteins expressed in a baculovirus vector, E. coli, etc. The invention additionally encompasses methods for detecting avian HEV nucleic acid sequences using nucleic acid hybridization probes or oligonucleotide primers for polymerase chain reaction (PCR).
    • 本发明涉及具有SEQ ID NO:1所示核苷酸序列或其互补链的新颖的分离型禽类戊型肝炎病毒。 本发明还涉及包含这种新病毒或重组产物(例如核酸和疫苗)的免疫原性组合物,其保护禽类或哺乳动物物种免受由戊型肝炎病毒引起的病毒感染或肝炎 - 脾肿大综合症。 本发明的范围还包括传播,灭活或减毒戊型肝炎病毒的方法,包括用活的致病性戊型肝炎病毒接种含胚鸡蛋,并回收该病毒或通过另外的含胚鸡蛋串联通过病原性病毒 直到病毒灭活或减毒。 此外,本发明涉及用于检测禽流感病毒感染或诊断禽流感或哺乳动物物种中的肝炎 - 脾肿大综合征的诊断试剂,其包含针对免疫原性组合物产生或产生的抗体,例如杆状病毒载体中表达的ORF2蛋白 大肠杆菌等。本发明另外包括使用核酸杂交探针或用于聚合酶链反应(PCR)的寡核苷酸引物检测禽类HEV核酸序列的方法。
    • 7. 发明授权
    • Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV)
    • 从猪繁殖与呼吸综合征病毒(PRRSV)分离的多核酸
    • US07517976B2
    • 2009-04-14
    • US11369944
    • 2006-03-08
    • Prem S. PaulXiang-Jin MengPatrick HalburIgor MorozovMelissa A. Lum
    • Prem S. PaulXiang-Jin MengPatrick HalburIgor MorozovMelissa A. Lum
    • C07H21/00C12N1/00C12N5/00C12N15/00C12P1/00C12N15/40
    • C07K14/005A61K39/00A61K39/12A61K2039/5254A61K2039/543A61K2039/552C12N7/00C12N2770/10021C12N2770/10022C12N2770/10034G01N33/56983Y10S424/815
    • The present invention provides a purified preparation containing a polynucleic acid encoding at least one polypeptide selected from the group consisting of proteins encoded by one or more open reading frames (ORF's) of an Iowa strain of porcine reproductive and respiratory syndrome virus (PRRSV), proteins at least 80% but less than 100% homologous with those encoded by one or more of ORF 2, ORF 3, ORF 4 and ORF 5 of an Iowa strain of PRRSV, proteins at least 97% but less than 100% homologous with proteins encoded by one or both of ORF 6 and ORF 7 of an Iowa strain of PRRSV, antigenic regions of such proteins which are at least 5 amino acids in length and which effectively stimulate immunological protection in a porcine host against a subsequent challenge with a PRRSV isolate, and combinations thereof, in which amino acids non-essential for antigenicity may be conservatively substituted. The present invention also concerns a polypeptide encoded by such a polynucleic acid; a vaccine comprising an effective amount of such a polynucleic acid or protein; antibodies which specifically bind to such a polynucleic acid or protein; methods of producing the same; and methods of raising an effective immunological response against a PRRSV, treating a pig infected by a PRRSV, and detecting a PRRSV.
    • 本发明提供了一种纯化的制剂,其含有编码选自由爱滋病猪繁殖与呼吸综合征病毒(PRRSV)的一个或多个开放阅读框(ORF's)编码的蛋白质的至少一种多肽的多核苷酸,蛋白质 与由PRRSV的爱荷华菌株的ORF 2,ORF 3,ORF 4和ORF 5中的一种或多种编码的那些编码的至少80%但小于100%的同源物,与编码的蛋白质至少97%但小于100%同源的蛋白质 由PRRSV的爱荷华菌株的ORF 6和ORF 7中的一个或两个,长度为至少5个氨基酸的这种蛋白质的抗原性区域,并且其有效地刺激猪宿主中的免疫保护,免于随后用PRRSV分离物攻击, 及其组合,其中对于抗原性不是必需的氨基酸可以被保守地取代。 本发明还涉及由这种多核酸编码的多肽; 包含有效量的这样的多核酸或蛋白质的疫苗; 特异性结合这种多核酸或蛋白质的抗体; 生产方法; 以及提高针对PRRSV的有效免疫应答,治疗由PRRSV感染的猪和检测PRRSV的方法。